Mapi – Pharma Ltd.
We are a clinical stage pharmaceutical company, engaged in the development of improved extended-release versions of existing commercially successful products, which we refer to as LCM products, that target large markets as well as high-barrier to entry and high-added value generic drugs.
|Address||Weizmann Science Park, 16 Einstein St. P.O. Box 4113, Ness Ziona, Israel 74140|
|Phone Number||+972 (73) 712-1213.|
|View Prospectus:||Mapi – Pharma Ltd.|
|Revenues||$0.6 mil (last 12 months)|
|Net Income||$-6.7 mil (last 12 months)|
|Price range||$15.00 - $17.00|
|Est. $ Volume||$50.0 mil|
|Manager / Joint Managers||JMP Securities|
|CO-Managers||FBR/ Maxim Group|
|Expected To Trade:|
|Quiet Period Expiration Date:||Available only to Subscribers|
|Lock-Up Period Expiration Date:||Available only to Subscribers|
|SCOOP Rating||Available only to Subscribers|
|Rating Change||Available only to Subscribers|